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ABSTRACT

The introduction of genetic testing has profoundly enhanced the prospects of early
detection of diseases and techniques to suggest precision medicines. The subtyping of critical
diseases has proven to be an essential part of the development of individualized therapies and has
led to deeper insights into the heterogeneity of the disease. Studies suggest that variants in
particular genes have significant effects on certain types of immune system cells and are also
involved in the risk of certain critical illnesses like cancer. By analyzing the genetic sequence of a
patient, disease types and subtypes can be predicted. Recent research work has shown that the
CNN's prediction quality within this context using gene intensity features could be improved when
the input is structured into 2D images.
Constructed from chromosome locations or from transformations involving kPCA, t-SNE,
etc., these two-dimensional images express certain types of relationships among the intensity
features. While this approach extends the success of convolutional neural networks to non-image
data, getting a precise mapping of features on the images to reflect the relationship among the
features is hard, if not impossible. To this end, we propose an enhancement to the approach by
providing the CNN training procedure with not only the samples of the structured image data but
also the samples from the unstructured raw gene expression data in its original form. While the
former is fed into the convolutional layers in the network, the latter is input only to the fully
connected layers of the network. The proposed method is applied to The Cancer Genome Atlas
(TCGA) dataset for cancer subtypes with the median values of the expression level of all expressed
genes in an RNA sequence. According to the experiments, our proposed approach can improve the
classification accuracy by 2.7% when it is applied to the state-of-the-art method with 2D CNN
architecture trained using images that are constructed based on chromosome locations of the
genes. When built on top of the method with 2D CNN architecture trained using images that are
constructed with transformation process involving t-SNE, classification accuracy is enhanced by
4.7%. For the implementation of the proposed approach on the 1D CNN model using the data
structured using covariance between the features, the classification accuracy is improved by 1%
and an increase of 3% is observed when the approach is implemented over the model trained using
1D CNN with data ordered based on chromosome locations.
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Chapter 1
Introduction
The classification of diseases into its subtypes has proven to be of immense significance in clinical
diagnosis and selection of targeted treatments. A group of symptoms can often lead to a diagnosis of a
variety of distinct disease subtypes that show a common set of symptoms but have a different prognosis
and different response towards the treatments. The precision medicine considers the heterogeneity of
a disease as a factor to establish the fact that visible symptoms can point towards different disease
subtypes and are detached from the underlying pathomechanism.
As per World Health Organization, Cancer ranks second in the list of leading causes of death which
accounted for nearly 10 million deaths in 2020. The diagnosis of cancer involves a comprehensive
analysis of the patient’s symptoms, results of physical examinations and results of screening tests. The
identification of the cancer subtype is an important step in cancer diagnosis. The diagnosis of a particular
cancer subtype helps in selecting the therapies, medicines and treatments which would be beneficial for
the patient. An early detection of cancer and its subtype increases the chances of a successful treatment.
Recent research in the context of disease subtype classification using machine learning techniques
suggest using the RNA expressions of the tumorous tissues corresponding to different cancer subtypes
and converting the non-image data into images to train a 2D Convolutional Neural Network. However,
the machine learning techniques tend to underperform due to the limited amount of data available for
research around the classification of cancer subtypes. It is a known fact that the Convolutional Neural
Networks are trained using the spatial and temporal relationships between the elements in the data.
During the conversion of non-image data to images, it is difficult to obtain a mapping of the features in
a 2D plane such that all the relationships exhibited by the raw data are preserved. The proposed
approach studies the possibility of improving the classification quality of the CNN when the samples
from the structured image data are used in tandem with the raw gene expression data by training the
convolutional layers using the image data and feeding the raw unstructured data to the fully connected
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network. In the same school of thought, 1D CNN can also be used to perform the classification using the
gene expression data. We study the implementation of 1D CNN governed by data structured based on
the covariance between the features and location of the genes on the chromosome. This research also
studies the impact of adding the raw data to the 1D CNN and analyze the gain in performance observed
by adding a supplementary input to the model training.

1.1 The Working Context
1.1.1 Cancer and its detection

Cancer is a deadly disease which is most associated with an abnormal gene function and an aberrant
gene expression pattern [1]. Despite a significant advancement in the field of detection and treatment
of cancer, it remains a most common cause of morbidity and mortality. Cancer is a term that represents
a class of diseases which leads to development of abnormal cells in a certain part of the body which can
spread to other parts of body and adversely impact the function of the normal tissues. The cancer is
assigned subtypes based on the organ or the tissue it impacts. The most reported symptoms of cancer
include fatigue, lump on the skin, changes in weight and skin, cough, joint pains, fever, and unexpected
bleeding.
The mutation of the genes leading to an abnormal behavior of the tissues is often referred to as the
underlying cause of cancer. A change in gene can lead to an aberrant growth of cells which continue to
divide leading to creation of new cells. Another reason is malfunctioning of the tumor suppressor genes
which prevents these genes to inhibit the growth of tumor cells leading to an increase in the count of
these unwanted cells. The failure of the DNA repair genes to repair the mutated genes also allows the
cells to become cancerous and divide. These gene mutations are either inherited from the parents or is
cause by the lifestyle conditions of the patient like smoking, exposure to radiations, obesity, hormones,
sedentary lifestyle etc. [2][3][4]
Typically, the cancer diagnosis is performed using the blood tests or analysis of the tissue that is
suspected to be infected. For analyzing the tissues, a part of the infected tissue is removed from the
patient’s body for studying. This process is known as biopsy. While analyzing the blood test results, the
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doctors look for the complete blood count which provides the counts related to various types of blood
cells in the body. An inflated blood cell count can point towards an abnormal cell division that can be
caused due to gene mutations. The abnormal rate of proteins in the blood cells are identified using blood
protein testing. Another method of diagnosis is using the tumor marker cells which are used like
transcripts for reference while studying the samples and an inflation in the amount of these cells can
lead to detection of a cancer in the patient [5]. Other forms of tests include the study of other bodily
fluids like mucus, urine etc. to identify any types of abnormalities in terms of the components of the
samples. As the cancerous cells divide and spread to other areas of the body, the detection of cell
present in one part of body in other parts of the body also helps in diagnosis of the cancer.
As per WHO [8], significant number of deaths can be averted by monitoring the risk factors and following
the prevention strategies. An early detection of cancer can help in reducing the morbidity due to the
cancer. The detection of cancer in early stages improves the possibility of the survival and, in some case,
the treatment can be started before the cancer begins to spread. In case a surgery is required for the
removal of the tumorous tissues, an early detection of cancer can facilitate in understanding the need
for the same and prevent the tumor from spreading into different parts of the body. The analysis of the
tumor markers is generally used in the process of early detection. The tumor markers are the biomarkers
for cancer and are found in blood and other bodily fluids and an elevation in the amount of these
biomarkers point out towards a cancerous condition. [6][7]
Machine learning techniques are often used to perform cancer diagnosis and prognosis due to their
ability to understand the patterns from complex datasets. This advantage promotes the use of these
techniques for usage in cancer prediction and detection and help in applications like predictive and
personalized medicines. Predictions related to cancer can be focused on risks that can be foreseen
related to cancer, reoccurrence of cancer and prediction of survival from cancer.

Figure 1: Kidney Cancer subtype classification
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The identification of a subtype of cancer is a crucial step for starting the treatment and therapies. The
classification of the cancer into its subtypes is often done based on the tissue it originates in or the part
of the body the cancer is found before the metastasis (transfer of tumor cells to other parts of the body).
For example, as shown in figure 1, kidney cancer is the cancer that originates in the kidney and can be
further classified into three subtypes based on the cell that the cancer has the impact on.

1.1.2 Precision Medicine

The initiative of precision medicine [10] was flagged off by the government of the United States of
America in 2015 with the National Institute of Heath and other partner institutions working to achieve
the vision of precision medicine. The fundamental idea behind the concept of precision medicine is to
provide a personalized treatment in response to a medical condition. This personalized medicine uses
the established clinical and pathological standards and the study of the genetic structure of the patient’s
tissues to create a precisely tailored diagnostics, prognosis and therapies or medicines that would help
in curing the disease. Precision medicine aims at studying the genomics of the patient to profile and
precisely target the subgroup of the disease using personalized medicines and therapies.
Precision medicine initiative can help in treatment as well as prevention of a medical condition taking
into account the variations of the genes in an individual, environment and lifestyle of the person. The
conventional diagnosis techniques involved prescription of the medicines and therapies based on the
knowledge about the treatments that would help an average person. This approach did not factor in the
individual difference between the persons that arise due to living style, environment etc. It is possible
that while one treatment that helps a person in curing a certain health condition, the same treatment
may not be effective for other person due to his different genomic structure or living conditions. Hence,
prescribing targeted agents by considering all the factors can not only help in treatment of the condition
but also help in reducing the side-effects from the medicine. [11]
The precision medicine initiative has two main components: short term goal of focusing on cancers and
a long-term goal of accumulating the knowledge base related to whole range of health and disease. By
the short-term goal, we would like to study the cancers and the genetics that is involved behind different
subtypes of cancers. Various research has been performed to study the biology behind the cancers and
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genetics to develop effective treatments for different types of cancers. This new way of understanding
the cancers has led to a deeper understanding about the inherited genetic mutations as well as the
variations inflicted during the lifetime and has led to positively influence the risk assessment, prediction,
prognosis, and therapies that can be used to suppress the impact of the tumor markers.
To achieve the long-term goal of generating the knowledge about the disease, there is a need to study
and analyze many more cancer genomes to achieve a deeper understanding of the different types of
cancer subtypes and cancer genomics. The data will be accumulated over a wider period of time as the
clinical trials are conducted which would help in compiling a database called as ‘cancer knowledge
network’ to preserve the digital form of the molecular and medical data which would contain the clinical
aspects related to the patients. This knowledge network would be instrumental in defining the observed
side effects, resistance to medicine or therapy. This knowledge would help the next generation of
researchers to create new detection mechanisms and treatments that would be beneficial for treatment
of cancer. As part of the long-term goal, the precision medicine initiative would be extended to other
diseases that would revolutionize the medical sector and bring tailored medicines and therapies to other
health problems. [10]
The idea behind precision medicine initiative relating to the tailored treatments is prevalent in different
manners in the medical sector. For example, when a patient requires an organ transplant, various factors
are considered before the procedure is performed. One of the major factors considered is matching the
organ donor based on donor’s age, blood type and organ size. The donors go through an extensive
evaluation to ensure that they can be a perfect match for the receiver and to assess their mental and
physical health. We can find multiple examples of tailored treatments similar to precision medicine but
the use of the same in the daily healthcare operations is limited. The Precision Medicine Initiative is a
giant leap in the direction to generalize the concept of early detection and personalized treatments to
be used in different areas of medicine and healthcare. [11][12]
A model approach for taking a step further towards the personalized medicines is development of
specialized tailored treatments for the patients for each subtype of cancer considering the quantification
and manipulation of patient’s genetic data. The subtype classification for the cancer using genetic data
from the patient will help in individualizing the treatment to specific tissues, gene mutations and other
factors related to a particular patient’s exclusive case of cancer. The model linking the use of precision
medicine with the cancer subtypes is called the Precision and Personalized Medicine (PPM) model which
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targets to replace the one-size-fits all approach with the use of personalized medicines and therapies
for cancer treatment. [46]

1.1.3 Genomic Data

Genomics is the study of the genes of an organism which focusses on mapping the genomes for that
organism and studying the function and the evolution of the genes. With the technical advancements in
the field of biotechnology, there are multiple types of genomic data that is available for the biologists
and researchers for studying. A genome is referred to as a complete set of DNA of an organism which
contains all of its genes. In our study, we will be using the gene expression levels that are determined
by high throughput DNA sequencing which determines the sequence of the nucleotides in the DNA.
Various types of analysis can be performed on the DNA which can help in deriving the information about
the proteins a gene encodes, similarity of one gene to another and mRNA expression levels. Each of the
genes provides very valuable information about the molecular function of the cell.
Since the genomic data is being collected and analyzed by many sources, this data is easily available for
use by different genomics projects that can perform their own experiments and analysis to derive
inferences and a different interpretation of data that can be used for multiple purposes. The genomic
data related to cancer is collected by National Cancer Institute and is widely available for different
institutions to use and perform analysis. Various organizations use this data to study the genetic
behavior and derive datasets like median gene expressions data, z-score of gene expression data, etc
that can be easily used for various algorithms and tools for performing the analysis.
The Precision Medicine Initiative is benefited from the vast wealth of genomic data available using which
the researchers can study the genetic composition of the human body and analyze the biomarkers
responsible for different types of cancers and other diseases. The genomic data also finds its application
in development of genomic medicines which can be used to treat specific diseases by understanding the
genetic bases of drug response and disease. [17]
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1.2 Problem Definition

For training a machine learning model implemented using Convolutional neural networks, the data
needs to be transformed before feeding it to the Convolutional Neural Networks. These transformations
can be conversion from text to images or reordering of the features in the dataset in order to introduce
a meaningful sequence in the data so that it can be efficiently processed by the Convolutional Neural
Networks. During these transformations, there is a loss of relationship between the features in the
dataset. The problem considered in this thesis is to look at suitable ways to compensate for the loss of
relationship among the features therefore advance the current state-of-the-art along this approach to
further improve the overall performance.

1.3 Thesis Motivation

The traditional method of diagnosis and treatment involves studying the symptoms of the patient and
prescribing the medicines. The traditional medicinal practices follow a one-size-fits-all approach. The
doctors prescribe the medicines based on their knowledge of the drugs that are helpful to majority of
the patients experiencing the same symptoms. However, every individual is different based on the
genetic composition of the body, and it is possible that if one drug helps in providing relief to one patient,
the same drug would not be helpful for another patient experiencing similar symptoms. Hence, studying
the genetic structure of the patient can be helpful in prescribing personalized medicines and therapies
that would help in providing relief to the patient.
The diagnosis of the disease is possible only when the symptoms start to appear in the body. However,
studying the genetic changes in the body can help in diagnosis of the diseases that are in process of
manifestation in the body and have not yet started to develop symptoms. This can be done by analyzing
the gene expressions of the patients and comparing it with those of a normal person to analyze the
genetic changes that can lead to a disease. Generally, the symptoms are a result of any genetic changes
that happen in the body over a period. Hence, if these changes are identified at early stages, the disease
can be diagnosed before it starts developing symptoms in the body. This would help in a timely and
accurate diagnosis and prognosis.
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In addition to this, a lot of diseases can be classified into multiple subtypes based on the underlying
causes or the organ or biological function it impacts. There is a tendency of different subtypes to alter
the body’s response to a medicine or therapy and a timely identification of the disease subtype can help
the doctors to prescribe the correct medicine/therapy.
From the machine learning perspective, the 2D Convolutional Neural Networks are most effective in the
case of data representing a visual imagery. Hence, to process the one-dimensional data, it must be
converted into images for training 2D CNN models. The conversion of the textual data into images lead
to a loss of relationship between the features which is expressed in the textual data. The design of the
existing state-of-the-art methods is successful in performing the classification tasks, but the limitations
posed by existing work provides a room of opportunity for an improvement in further elevating the
quality of classification. This research aims to propose a new method to improve existing methods by
overcoming the loss incurred due to the conversion of data into images and designing a neural network
architecture which can leverage the information gained from both the images and the original dataset
without increasing the complexity of the system. This research aims to propose an architecture with
improved performance and classification accuracy that would be using the original input data in addition
to the transformed data. In this way, the proposed method would be leveraging the feature extraction
and summarizing functionalities offered by the convolutional neural networks and use the information
from the original dataset to compensate for the loss of information occurred due to the data
transformation.

1.4 Thesis Contribution

This thesis work addresses the issue of loss of information that occurs due to the transformation of data
from one format to another and proposes a novel technique for improving the performance of machine
learning methods implemented for cancer subtype classification. The proposed method uses the twodimensional Convolutional Neural Network to perform the classification task and supplements the
neural network with the original gene expression data to compensate for the loss of relationship
between features incurred due to the transformation of textual data to images for training the
convolutional neural network.
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The proposed approach overcome the limitation of lack of availability of data for training the
Convolutional Neural Networks by using the same input source in its original format to act as a
supplementary source of data for training the machine learning model. Using this approach, the same
set of data is used in different parts to train the components of the machine learning model.
It is quantitatively proved that introducing redundant input to the deep neural network in this setting
can further improve the overall performance.

1.5 Thesis Organization

The rest of the thesis is organized in the following manner:
In Chapter II, we present the machine learning techniques like neural networks and convolutional neural
networks that are used for addressing the classification problems. We also present the most widely used
dimensionality reduction techniques that are used for visualization and analysis of high-dimensional
data.
In Chapter III, we present the related work and literature that explains about cancer subtypes, need for
classification of cancer into subtypes, various classification methods in computer science used for
performing the cancer subtype classification. This section also discussed the prevalent state-of-the-art
techniques implemented for cancer subtype classification.
In Chapter IV, we discuss our proposed approach for cancer subtype classification implemented using
the 2D convolutional neural networks that can be trained using the gene expression data. We discuss
the reasons for the loss of information incurred during the transformation of the data into images. We
also explain the various machine learning approaches that we compare our model with to evaluate its
performance.
In Chapter V, we explain the dataset used for performing the experiments along with the experimental
setup with technical details of the platform the convolutional neural network setup. We provide
information about the dataset used for training the machine learning models and performing the
evaluations. We also present the results of the experiments conducted on the proposed approach and
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compare the same with the methods chosen for evaluating and comparing the performance using
classification accuracy and precision.
With Chapter VI, we conclude the research highlighting what can be drawn from the results obtained
and the scope of future work that can be taken up using the proposed approach.
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Chapter 2
Background
This chapter describes the technical background of the study including the technologies related to this
research. We discuss the widely used machine learning methods i.e., neural networks and convolutional
neural networks along with the various components that are used in these methods. For performing the
analysis for the study, we have used a data set with large number of features. We use dimensionality
reduction techniques to perform the transformation of the data to visualize the data onto a twodimensional space.

2.1 Neural Networks

Artificial neural networks play a very important role in solving supervised learning problems. In
supervised learning, the algorithm tries to predict the labels or target classes corresponding to the
patterns observed in the input. While training a supervised model, the training data contains the
information about the labels corresponding to the data in which patterns can be observed for model
learning. For example, in a spam filter developed using machine learning algorithms, the training data
contains the emails and the corresponding labels (spam or ham) which would help the machine learning
model to learn the relationship between the patterns observed in the training data and the
corresponding labels. [13]
Neural networks are computational constructs which mimic the working of a human brain’s neural
network. An artificial neural network consists of multiple neurons which performs a mathematical
operation on the inputs and produce an output. A network of neurons can be used to perform machine
learning tasks like classification, predictions etc. Neural Networks are widely implemented to solve
machine learning problems in areas like information security, big data, cloud computing, healthcare,
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banking, and financial sectors, etc. The neural networks are widely used in applications where a large
amount of data needs to be processed for model learning as they can easily process data with huge
number of features and understand the underlying patterns in the data to perform the classification or
prediction tasks.

Figure 2: Representation of a neural network where X1 and X2 are the inputs which translate into output O1. W(x,y) are the
weights associated with the input X

Figure 2 represents a neural network which is trained with the data containing two features x1 and x2
and has three neurons in the hidden layer which performs a mathematical function using the weights
(w) and a bias value (b). A bias value is added to the computation to adjust the output of the weighted
sum of the inputs so that the model can best fit to the given data.
𝑛

𝑓(𝑥) = ∑ 𝑤𝑖 𝑥𝑖 + 𝑏

(2.1)

𝑖=1

The output that is computed by neurons in the hidden layer is computed using equation 2.1 where,
𝒙𝒊 is the value of the input to the neuron received from the ith neuron,
𝒘𝒊 is the weight associated with the neuron i, and
b is the bias value
n is the total number of inputs provided to that neuron
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The output of the neuron is computed using an activation function which induces a non-linearity in the
output. This non-linearity is significant in computing the output of the neuron because most of the data
available for a real application is not linear and an activation function helps the model to understand
and learn as per the nonlinear data and would perform better when the model is used over the realworld data. There are different activation functions that can be selected for performing the activation
in the neural network:
Sigmoid activation function: This function is used to transform the value in range of 0 and 1 by using
the function f(x) = 1/(1+e-x)
Tanh Activation function: The hyperbolic tangent function is similar to sigmoid function but is symmetric
around the origin. Tanh is continuous and differential function which results in output between -1 and
1. The function can be represented as f(x) = 2*sigmod(2x) -1.
ReLu function: Rectified Linear Unit function is a non-linear activation function and is widely used in the
convolutional neural networks. It uses the concepts that all the neurons are not activated at the same
time in the network. To select when to deactivate the neuron, the activation function returns 0 if the
input is negative. It can be mathematically defined as f(x) = max(0,x).
Softmax Activation function: This function is a combination of multiple sigmoid functions. Softmax
function is used for calculating the probability distribution for multiclass classification problems. This
function outputs the probability corresponding to the various classes into which the data can be
classified into. [15] [16]
As the signal flows in the neural network, the output of one neuron in a hidden layer is fed into the
activation function of the neuron from another hidden layer to decide which nodes need to be fired.
This computation results in feature extraction from the data. Hence, during one forward propagation in
the data, the weights are trained and transferred throughout the network contributing to the output of
the neural network.
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2.2 Convolutional Neural Networks

Convolutional Neural Networks is one of the state-of-the-art classification techniques used for image
classification tasks. Convolutional Neural Networks is an improvised form of neural networks. Neural
networks are complex computation constructs that leverage the underlying relationships in a set of data
using the learning techniques that are inspired by the animal brain. Neural networks are constructed
with several computational units that mimic the neurons present in the human brain. These neurons are
trained to determine the patterns in the inputs and determine the weights on the neurons, which are
adjusted as the neural network is trained using different training samples. The trained model can be
functional in tasks pertaining to classification and prediction.
Convolutional Neural Networks are widely used to solve classification problems, and the twodimensional CNNs are instrumental in performing analysis and classifications using visual imagery.
Convolution is a mathematical concept which looks for a function ‘c’, which quantitatively expresses the
impact of function ‘a’ on the shape of function ‘b’ and describes the relation between function ‘a’ and
‘b’. Typically, in a simple CNN network, the first layer of a convolutional neural network is the input layer
which initializes the neurons based on the number of features in the input to the network. Hence, it has
the same number of neurons as the features in the input. After the input layer, the convolutional layers
come into the action and perform the feature extraction from the images by summarizing the inputs.
The output of the convolutional layer is passed to a pooling layer which reduces the dimensions of the
output of the convolutional layers by combining the neuron clusters into a single neuron based on
functions like average, maximum values etc. The count of the combination of convolutional and pooling
layers can be placed serially to improve the classification quality. The output is then passed through a
flattening layer that reduces the output's dimensions to only the classification output. Finally, there is a
densely connected layer with different types of neurons for the probability distribution over various
classes.
The basic concept behind using the convolutional layers is to convolve the inputs and summarize them
and reduce its dimensions. The convolutional layers prove their significance when the inputs are in the
form of images and are comparably large to be processed by the fully connected feed-forward neural
networks. In figure 3, the input is in the form of a 2D array, and a kernel containing a small matrix of
weights slides over the input and performs element-wise matrix multiplication and then sums up the
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result to converge the output to a single cell. This matrix multiplication process with a smaller matrix of
weights is repeated as the kernel slides over the entire input matrix to yield another matrix of a reduced
dimension. The size of the kernels determines the size of the output feature of this layer. Multiple
kernels can be used for a convolutional layer, and their outputs are combined to get the final output
feature matrix.

Figure 3: Convolution of features using filters

The convolutional layer has an activation function as a component to introduce a non-linearity in the
output. We have used Relu as the activation in the convolutional layer. ReLu is a piece-wise linear
function that output the input value if the value is positive, and it outputs 0 if the input is negative. The
formula for ReLu is expressed in equation 2.2:
𝑥,
𝑓(𝑥) = {
0,

𝑥≥0
𝑥<0

(2.2)

The output of the convolution layer can be mathematically expressed in equation 2.3:
𝑙
𝑥𝑗,𝑘
= µ(𝑧)
𝑝

𝑤ℎ𝑒𝑟𝑒 𝑧 = (𝑦

where:

𝑙−1

+

𝑞

𝑙−1 𝑙−1
∑ ∑ 𝑤𝑚,𝑛
𝑥𝑗+𝑚,𝑘+𝑛 )
𝑚=0 𝑛=0

(2.3)
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𝑙
𝑥𝑗,𝑘
= activation result of 𝑘 𝑡ℎ neuron at jth row at lth layer in the input matrix

yl-1 = bias shared among the lth layer
𝑙−1
𝑤𝑚,𝑛
= weight parameter at position (m,n) in the filter matrix of size 𝑝 ∗ 𝑞

𝜇 = activation function

Figure 4: Transformation of convolved matrix using pooling layer

The output of the convolutional layer is passed through a pooling layer, which helps reduce the
dimensions of the parameters. As depicted in figure 4, it is used for down-sampling to increase
computation speed and improve the quality of features extracted by retaining important information.
Like the filters in the convolutional layers, the pooling layer has filters that slide over the input to this
layer and compute the output. There are multiple types of pooling, out of which Max Pooling and
Average Pooling are most used. In Max Pooling, each filter selects the maximum value from the patch
on the feature map to create a reduced map. On the other hand, the Average Pooling filter calculates
the average values on the patch on the feature map to construct the reduced map. We have used Max
Pooling in our experiments.
In a deep neural network using the convolutional layers, multiple sets of convolutional and pooling layers
are used to improve the feature extraction from the input and retrieve the most important information
or feature values.
After the input is processed using the convolutional and pooling layers, the output is flattened to convert
the matrix into a vector to feed it to the fully connected layers. [24]
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2.3 Dimensionality Reduction

The dimensionality of data corresponding to any domain increases with the number of features captured
and quantified for that domain. The real-world data such as speech, text, images, videos, medical
imagery etc. has a very high dimensionality that needs to be decreased so that the machine learning
algorithms can effectively process that data. The dimensionality reduction in the data can be performed
in two ways- one is to select only the features that are most relevant from the original dataset which is
known as feature selection. The second method is to compute a second set of variables that can be
expresses as a combination of more than one features in the dataset. Dimensionality reduction is
performed in many cases to visualize the data in an understandable manner. The reduction in
dimensionality must be done in such a way that while reducing the dimensions, we should not be losing
any vital information. [18][19]
Ali Ghodhsib [19] defines dimensionality reduction as a process of deriving a set of degrees of freedom
which can be used to reproduce most of the variability of the data set. These techniques produce a
condensed visualization of the given high dimensional dataset in such a way that the low dimensional
representation retains the maximum possible properties from the high dimensional dataset.
Dimensionality reduction is also instrumental in noise reduction, cluster analysis, data visualization etc.
and is commonly used in the machine learning solutions like signal processing, speech recognition,
neuroinformatic and bioinformatics.
There is a plethora of dimensionality reduction techniques available and each of them have a different
mathematical insight behind them. Some of the most widely implemented dimensionality reduction
techniques in the machine learning problems are Principal Component Analysis (PCA), kernel Principal
Component Analysis (kPCA), T-distributed Stochastic Neighbor Embedding (tSNE), Linear Discriminant
Analysis (LDA), Auto Encoder, etc.
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2.4 Principal Component Analysis

Principal Component Analysis (PCA) is one of the most widely used unsupervised learning algorithm for
dimensionality reduction which focuses on preserving the variability in the data while reducing the
dimensions. The main idea behind PCA is to preserve the information possessed by the data set and
derive new variables which are linear functions of the variables in the dataset. With this reduced dataset,
the limitations associated with high-dimensional data like high computational expenses and increased
error rate due to large number of features in the dataset can be mitigated. PCA is also widely used to
visualize the high dimensional dataset for analysis.
Consider a dataset containing n number of samples and p number of features. We can visualize the
samples on a number line if we want to analyze the values in samples corresponding to one feature.
Similarly, if we want to analyze two features from the dataset, the values can be visualized using a twodimensional graph. In the same manner, three features can be visualized on a 3D graph. However, for
visualizing more than 3 genes, we cannot visualize them as they would need more dimensions for
plotting them on a graph. To overcome this limitation, PCA is used for visualization of the data that has
high dimensions.
To perform the principal component analysis on the dataset, the values in the data are normalized first
so that they can be standardized to a range and the contribution of each feature can be determined
easily and the values can be compared with each other. Normalized values for a data point can be
calculated by using mean and standard deviation as per the formula in equation 2.4.
𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑣𝑎𝑙𝑢𝑒 =

𝑣𝑎𝑙𝑢𝑒 − 𝑚𝑒𝑎𝑛
𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛

(2.4)

After the standardization process, the covariance matrix is calculated which represent the relationship
between the features. The covariance values represent how the values of 1 variable change with respect
to another variable. The covariance matrix represents two types of relations which can be identified by
the sign of the covariance value. If the value is positive, then the two variables are highly correlated to
each other i.e., their value increases or decreases simultaneously. If the value is negative, it represents
that the values are loosely correlated and the value of one variable increases when the other decreases
and vice-versa.
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After deriving the covariance matrix, the eigenvalues and eigenvectors are calculated from the
covariance matrix to calculate the principal components. Mathematically, an eigenvector is a direction
vector which points in the direction in which it is stretched by transformation. The eigenvalues represent
the extent of the extension of the vector. The eigenvectors derived from the covariance matrix represent
the direction of an axis in which the maximum covariance is observed which tantamount to maximum
information that can be derived from that point on the graph. These are known as the Principal
Components and the eigenvalues associated with the eigenvectors represents the variance present in
those principal components. The principal components are then derived by ranking the eigenvectors
based on the eigenvalues. The eigenvectors with the highest eigenvalue represent the principal
component of highest significance. Based on the ranking from high to low, different principal
components are determined in order of decreasing significance (variance). Using these ranked
eigenvectors, a feature matrix is formed that contains the eigenvectors that we wish to keep. Hence,
the dimensionality reduction comes into the picture when we drop these columns and keep only the
values (principal components) which are of higher significance.
Using the resultant feature matrix, the original data is transformed to represent all the points on the
axis on which the Principal Components can be plotted. [21][22]

2.5 t-Distributed Stochastic Neighbor Embedding (t-SNE)

t-Distributed Stochastic Neighbor Embedding (t-SNE) is also a dimensionality reduction technique which
is an unsupervised algorithm like PCA. The difference between PCA and t-SNE is that PCA tends to
calculate the principal components based on maximum variance and largest pairwise distances between
the points while t-SNE preserves only the local similarities in the data by preserving the small pair-wise
distance. [23]
The t-SNE algorithm works by visualizing the data points in a Gaussian distribution and calculate the
probability distribution over that Gaussian distribution to determine similarity of the points to the ones
in their neighborhood as shown in figure 5. The probability is calculated by determining based on the
chance of point ‘a’ selecting point ‘b’ as its neighbor. The size of the Gaussian distribution area can be
manipulated by changing the perplexity in the algorithm.
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After computing these probabilities, the algorithm calculates the Cauchy distribution to calculate the
second set of probabilities on a low-dimensional space. The algorithm tries to minimize the difference
between the probabilities calculated over a high dimensional space and a low dimensional space. This
helps in improving the representation of data in the lower dimensional space which the t-SNE algorithm
tries to derive.

Figure 5: Gaussian Distribution around data points

For representing the probability distribution for the high dimensional space using the low dimensional
space, the algorithm tries to minimize the sum of difference in the probabilities. This is done using the
Kullback-Liebler divergence method. This method determines the divergence of one probability
distribution from another probability distribution using the gradient descent method. In this way, the tSNE algorithm tries to map the data from a high dimensional space to a low dimensional space and tries
to find patterns using which it can identify clusters which can be visualized in a reduced dimension. [23]
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Chapter 3
Related Work
This chapter provides a brief overview of the research conducted in disease sub type classification and
the use of machine learning techniques as a solution to the classification problems in the field of
bioinformatics. We will be discussing the model that we used as a baseline for our proposed approach.
We study the state-of-the-art methods for disease subtype classification which we have used to
compare our proposed approach to. We analyze the related works of literature that are relevant in
understanding the disease subtype classification and the use of convolutional neural networks in solving
this classification problem.

3.1 Disease Subtype Classification

Health care has evolved with time to incorporate techniques that can be implemented to prevent,
detect, and cure many chronic diseases to decrease the mortality rate associated with them. The
modern pathological studies have broken the conventional techniques of studying a human biological
system as a black box and new techniques and technologies has provided a deeper understanding of the
human systems to facilitate targeted treatments of the disease. The study of medicines and pathological
cures has undergone a revolution with the advent of the genetic testing. The principles of curing a
disease in order to increase the life expectancy, typically focusses on 4 P’s namely prediction,
prevention, personalization and participation [25]. The predictive analysis work on predicting a disorder
or a reaction to medicine by means of the catalogued medically relevant mechanisms that helps in
foreseeing the occurrence of a medical condition based on variations in chromosomal architecture and
genes. Prevention of a disease is based on a prediction of a future emergence of a health condition in
patients and the design of the preventive drugs that can be used to stop the emergence of the disease
or help in curbing the effects related to a disease. The personalization of medicine is important because
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every individual differs in terms of body structure, genetic composition, and the environment that he
lives in. Hence, in some cases a drug that can cure on individual would not help another person with the
same disease. Hence, to accommodate these variations, each individual should be treated differently
from others and taking in account the conditions of a person, a medicine should be tailored based on
this personalized study. The principal of participation involves the contribution of the individuals as well
as medical institutions towards the study of disease and medicines and collectively help the healthcare
industry to adapt to patterns observed in diseases and collectively help in the development of cures and
medicines.
The precision medicine initiative by the National Institute of Health and other partners [26] have
provided a new dimension to the 4 P’s discussed. The concept of precision medicine involves analyzing
an individual’s genetic changes by means of genomic sequence, microbiome composition, health history,
lifestyle, and diet. This approach is a considerable improvement over the conventional techniques that
involves prescription of a medicine based on symptoms observed which led to an uncertainty about the
effectiveness of the medicines. This approach studies the genetic changes in the body to predict or
diagnose a disease and used in prescribing a tailored treatment in form of medicines and therapies which
would be most effective to the patient.
Studies in disease subtype classification have used various machine learning based classification
techniques including neural networks, random forests, support vector machines and so on. The recent
work by Gao et. al [27] focuses on cancer molecular subtype classification using the DeepCC method
which is a supervised and knowledge-based framework for cancer classification. For the gene expression
data, they convert it into a functional spectrum using the Gene Set Enrichment Analysis [28] using which
a vector is derived to represent the molecular patterns by means of enrichment scores. They use these
vectors as an input to train the multilayer artificial neural networks. The authors claim that the DeepCC
technique demonstrates a superior performance over other popular machine learning techniques like
Random Forest, Support Vector Machine, Logistic Regression and Gradient Boosting Machine. The
authors performed experiments on the gene expression data for two types of cancers – colorectal cancer
and breast cancer. This study demonstrates that the neural networks perform better than other
classification techniques for classification of disease subtypes using the gene expressions.
A study by Wen et. al [29] suggests using the long chain non-coding RNA and mRNA as the input for
classification models that can classify the data into lncRNA and mRNA as both these gene transcriptions
are related to many biological activities. Since the dataset used by the researchers contained the genetic
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sequences instead of the intensity levels of the genes, they performed a k-mer analysis on the data to
derive the frequency of various combinations of subsets of the transcripts of gene expressions. Using
the frequencies derived from the datasets, they train the classification models for performing the
predictions. From the results obtained, the authors compare the accuracy, precision, recall and F1 score
among convolutional neural networks, random forest, logistic regression, decision trees and support
vector machines and claim that the CNN is superior in performance as compared to other techniques.
The method proposed by Lee et. al [30] used the biological pathways instead of genomic sequences for
cancer subtype classifications. A biological pathway is a series of changes in the molecular interactions
in certain conditions that lead to a biological function in a cell [31]. These pathways are crucial for
understanding complex biological functions and can point towards a specific pathway of changes
adopted that changes the biological composition of a cell to cause a certain condition. Due to this, the
biological pathways can be used for classifying disease subtypes. The authors use a Graph Convolutional
Network model to extract the patterns from the pathway model and perform the cancer classification
based on the ensemble setup that analyses the probabilities from different pathways representing a
specific cancer subtype. Using the ensemble predictions, they derived the probabilities associated with
the cancer subtypes and select the highest probability to label an input with the cancer subtype.
The classification of disease subtypes can be performed using various types of data that include gene
expressions, blood sample slides, clinical data etc. Wang et al [32] propose a different way of performing
the disease subtype classification by using the whole slide images of a pathologist’s delineation of
regions of metastatic cancer on sentinel lymph nodes. They preprocess the images from RGB to HSV
(Hue Saturation Value) color space and then generate the final mask of the images by combining the H
and S channels. The authors used deep learning network architectures like GoogLeNet, AlexNet, VGG16
and FaceNet for evaluating the performance using the images derived. They varied the magnification
level on the images to perform experiments using different settings and claim to have received the best
performance using 40x magnification level images using the GoogLeNet architecture.
Selection of the features play an important role in the quality of the subtype classification. The features
are measurable characteristics in a dataset which have values that vary from one sample to another.
The selection of the most important features is important in order to ameliorate the noise from the
dataset which may contain information that would not help in classification and might degrade the
performance of the classification model. Cai et. al [33] performed the experiments related to subtype
classification and survival prediction in Diffuse Large B-Cell Lymphomas. They used the gene expression
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profiles and clinical data of patients from a molecular profiling initiative of National Centre for
Biotechnology Information and used 11,271 gene expression levels of each subject. They performed
feature ranking using Maximum Relevance Minimum Redundancy (mrMR) principal which focusses on
selecting the features which provides large amount of information corresponding to the target variables
and are unrelated to each other. They coupled this technique with Incremental Feature Selection to
choose 35 gene signatures to train the classification model. They performed classification of the samples
into four groups using the Nearest Neighbor Algorithm.

3.2 Classification Techniques and Methods

As a part of literature review, we studied various classification techniques that can be used for disease
subtype classification and selected Convolutional Neural Networks as our base model based on the
analysis related to performance and complexity. For performing the classification tasks, other methods
like Naïve Bayes, Random Forest, Logistic Regression, Decision Tree etc are widely used. [27].
Random Forest [36] is a classification method that uses a combination of decision tress to perform the
prediction or classification tasks. This method includes training multiple decision trees using the bagging
and bootstrapping techniques that helps in training different decision trees with subsets of the original
dataset and form an ensemble of the decision trees that can combine their output to predict the
variable. Wenric et. al [35] implemented the Random Forest algorithm on the TCGA gene expression
dataset for performing the classification task.
Naïve Bayers [27] classifiers use the probabilities calculated using the Naïve Bayes theorem. Xiong et. al
[38] implement a cost effective Naïve Bayes based classifier to use the gene expression data for cancer
classification. Their proposed method calculates the cost of classification based on the accuracy of the
predictions such that a correctly classified sample reflects no cost on the system while a cost is added
when a sample is misclassified. Their proposed model tries to reach the optimal solution by minimizing
the cost of misclassification.
Convolutional Neural Networks can be used for classification of data both for textual [40] and those that
represent visual imagery [39]. Convolutional neural networks can be implemented for the gene
expression data by using the gene expressions both in the textual format and image forms. Motsavi et.
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al [41] implemented the convolutional neural networks for cancer subtype classification and compared
the performance of the models using one dimensional CNN, two dimensional CNN and hybrid CNN. They
have used the tumorous samples and non-tumorous samples into their designated cancer types. Their
study involved the dataset with the normal samples in order to perform classification to detect the
presence of cancer. They proposed a hybrid approach using the 2D Convolutional Neural Network in
which they implemented a parallel CNN architecture with different configuration of the filters for the
convolutional layer to read the data horizontally and vertically respectively for each arm in the parallel
setup as shown in Figure 6. After the convolutional and pooling operations, they merge the outputs of
the layers by concatenation and then process it using the fully connected layers.

Figure 6: Representation of the versions of convolutional neural networks implemented by Motsavi et. al [41]
Image Source: Mostavi, M., Chiu, Y. C., Huang, Y., & Chen, Y. (2020). Convolutional neural network models for cancer type
prediction based on gene expression. BMC medical genomics, 13(5), 1-13.

3.3 DeepInsight: A methodology to transform a non-image data to an image for
convolution neural network architecture.

Convolutional Neural Networks are widely used for classification of the data representing visual imagery
and can be in the form of images, video, graphs etc. Our proposed approach uses the gene expression
data for training a model implemented using the 2D convolutional neural networks. Since, the intensity
levels of the expresses genes in a tumor sample are available in textual forms, there is a need of
converting these expression values into images in order to use the 2D Convolutional Neural Networks.
Sharma et. al proposed a methodology to transform non-image data to images for training a
convolutional neural network to perform the classification.
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The authors proposed a generic approach which they implemented and tested using datasets containing
data related to RNA-seq, vowels, text and artificial datasets. They designed an approach that transforms
a feature vector derived from the dataset to image pixels. Their proposed approach gives importance to
the arrangement of information as the right positioning of the elements on a plane can denote the
relationship between the elements and provide significant edge while training the classifiers.
The authors implement the idea of placing similar elements or features close to each other and placing
the dissimilar features at a distance. In this way, they instill a relationship between the features and use
the neighbouring elements to represent the underlying relationship between the features while using
the convolutional neural networks. In this manner, they create clusters of similar features, and they
claim that this arrangement provides a better classification accuracy compared to the approach of using
these features individually. This approach throws a light on the techniques that can be used in order to
use deep learning networks using textual data which widens the scope of areas in which these algorithms
can be applied.
The gene expression in the data are converted into a matrix representing the features. Before
performing the transformation of non-image data to images, all the gene expression intensity values are
normalized using minimum and maximum values. The placement of the features in this matrix is done
in such a way that the similar features are placed close to each other. Using a transformation T, the
location of each feature in the matrix is determined and based on these locations, the expression values
from each sample are populated in the matrix to convert it to images. In this way, a unique image is
generated for each sample.
Since the TCGA gene expressions data has a large number of features representing 20,531 genes which
leads to an increase in the dimensionality of the data, a dimensionality reduction technique is used to
visualize the data. The authors suggest using nonlinear dimensionality reduction techniques like tSNE or
kernel principal component analysis (kPCA) for performing the transformation of the data into images.
On applying these techniques, the features can be visualized or organized on a 2D cartesian plane with
each point on the plane representing the location of a gene.
After determination of the locations, convex hull algorithm is used to calculate four points in the plane
and create the smallest possible rectangle using those four points to enclose all the points. This step is
done to calculate a convex envelope in the shape of a rectangle that can be rotated as a frame of
reference to align the points with the axis. After the rotation is performed on the rectangle obtained,

27
the position of the points on the frame are fixed. After this, the values of the gene expression for each
sample are mapped to the corresponding location on the matrix for each gene.
In this process, if two features are placed at the same location on the matrix, the values for both genes
are averaged before setting the value on the plane. In case of large number of features being placed on
a 2D plane, overlap of features is a common phenomenon in this transformation which may lead to
images which would not be true representation of the data.
Once the images are obtained corresponding to all the samples, these can be used to train a
convolutional neural network for performing the classification of the data into classes. This approach
can be used to convert any type of non-image data represented using multiple features. The authors use
this approach to convert the datasets related to RNA gene expressions, vowels from TIMIT AcousticPhonetic Continuous Speech Corpus, textual datasets, Madelon dataset and Ringnorm dataset.

3.4 Deep Learning based tumor type classification using gene expression data

In their work, Lyu et. al [43] argue the importance of differential studies over the conventional methods
that involve classifying a tumor sample using a normal sample which is of the same cancer type. In their
proposed method, they use multiple subtypes of cancer from Pan-Cancer Atlas dataset to train their
classification model to identify various types of cancer. They perform this experiment to propose a
method to overcome the limitation of using only one cancer type. The conventional methods involve
matching the tumor sample to a normal sample where both samples belong to same tumor type. These
methods tend to incorrectly classify the cancers due to their limited knowledge on variability of the data
in the samples due to other cancer types.
The authors performed experiments to train a deep learning neural network model implemented using
convolutional neural networks and make classifications for 33 tumor types. They also perform
experiments to identify gene biomarkers that can be associated with a certain type of tumor. They use
the Guided Grad Cam method [44] to generate heat maps using which they identify the genes that relate
to a specific type of tumor.
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Figure 7: Architecture of the method proposed by Lyu et. al

Figure 7 highlights the architecture designed by the authors in their research. They used the PAN Cancer
Atlas dataset containing normalized RNA-seq gene expression values for 33 tumor types distributed
among 10267 samples. They performed normalization of the data using the log normalization method
to reduce the noise in the data using the equation defined in 3.1. The result of log normalization returned
0 for the values less than 0.
𝑦 = log (𝑥 + 1)

(3.1)

The data contains gene intensity levels for more than 20,000 genes. To reduce the dimensionality of the
dataset, they used the annotation file from NCBI to filter out the genes that were not present in the
annotation file. They further processed the data to remove the gene values that would not contribute
to the classification outcome. To do so, they calculated the variance of the genes in the dataset and
removed those genes that had the variance value lower than a threshold value set by the authors. They
perform this step to remove the genes that do not vary in the dataset as per the cancer types and have
values that remain unchanged. Using the above stated pre-processing, they claim to have reduced the
number of genes from 20,531 to 10,381.
The authors have transformed the resultant gene expression data into images by embedding. They
perform reordering of the genes based on the chromosome number on which the gene is present. They
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perform this step to instill a sequence in the genes as the genes that are located next to each other on
a chromosome tends to interact more whenever a genetic disturbance or mutation is experienced.
For conversion to images, they convert the data into a 2D matrix of size 102 x 102 and place the values
from the processed gene expression dataset into the matrix. Since, this square matrix can fit 10,404
values, they append zeros to the data set at the end of the matrix. After embedding this matrix into
images, they perform normalization of the data to ensure that the values lie in the range of [0,255].
Using the images obtained, the authors train a deep learning neural network implemented using the
convolutional neural networks. They perform the classification and evaluate the model using
performance metrics like accuracy, precision, recall and f1-score.
To further evaluate their proposed approach, they identify the genes that can act as biomarkers and
indicate a change in their expression values due to occurrence of a specific type of cancer subtype. They
use the activation maps and gradient maps obtained during the forward and backward propagation
during the model training to generate heat maps using the Guided Grad-Cam technique. They combine
the heat maps corresponding to the samples for each class to get an averaged heat map. They identify
the genes that contribute to a certain type of cancer by identifying the pixels corresponding to the genes
which have higher intensities in the heat maps. They claim to have performed the analysis of the top
genes responsible for occurrence of certain cancer subtypes and identify the relation of those genes to
occurrence of cancer.
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Chapter 4
Proposed Approach
Targeted cancer treatment based on the cancer subtype has been a topic of clinical interest in cancer
research. The precision medicine approach considers the individual variability in the genes and other
factors. However, due to limited data available for research, the machine learning techniques that are
used to train the classification models tend to underperform. In addition, several machine learning
approaches use Principal Component Analysis during the data pre-processing steps, that often leads to
a loss of information that can be extracted from the raw dataset. To overcome these limitations, we try
to fully incorporate the information that can be extracted from the raw data so that the machine learning
techniques can be leveraged without any information loss and the impediments caused by the limited
data availability for processing. We introduce an approach that can take advantage of the relationship
between the features expressed in the raw data lost during the data processing step and performs the
classification task by using a model trained using the Convolutional Neural Networks.

4.1 Architecture

The architecture of the proposed model is depicted in figure 8. Figure 9 shows how the 1D data can be
converted into images. We follow the DeepInsight method for the conversion of non-image data into
image data. After converting data to images, a 2D CNN network is trained, and the CNN network's output
is then passed to the fully connected layers. In addition to the output from the CNN layers, we also pass
the unordered dataset to the fully connected network. Hence, we can say our proposed model can be
divided into four major components:
1. Conversion of non-image data to image data
2. 2D Convolutional Neural Networks
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3. Adding raw data to fully connected layers
4. Classification using a softmax activation function
These steps ensure that classification is performed on the gene expression level, and any information
loss occurred due to the conversion of non-image data to images is compensated by passing the
unordered dataset to the fully connected layers to achieve a better performing deep learning model.

Figure 8: Architecture of the proposed model

4.1.1 Conversion of non-image data to image data

The 2D Convolutional Neural Networks are considered a state-of-art architecture for performing the
image classification task. The DeepInsight method focuses on leveraging the classification offered by 2D
CNN by converting the non-image data into images and using the 2D CNNs to train the classification
model using the images.
Firstly, we read the data from the files containing the median values of gene expression levels for all the
expressed genes in an RNA sequence corresponding to tumor samples. Then we combine the data into
one data frame and performed MinMax scaling on the data. The MinMax scaler translates the value of
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each feature individually such that the value is converted into a specific range for the training set. The
formula used for scaling in a range of (0,1) is expressed in equation 4.1:
𝑥𝑠𝑐𝑎𝑙𝑒𝑑 =

𝑥 − 𝑥𝑚𝑖𝑛
𝑥𝑚𝑎𝑥 − 𝑥𝑚𝑖𝑛

(4.1)

Feature selection before image transformation is not essential in this case, as the DeepInsight method
involves implementing dimensionality reduction techniques like t-SNE, which provide informative
embeddings and clusters of the data based on the neighborhood of the features. If feature selection is
performed in this case, there is a chance that we may lose information represented by the original
dataset, which may lead to an inefficient representation of data points on a lower dimension. We use
the DeepInsight method to convert data into images, which transforms the list of features into a matrix
using a transformation scheme. This transformation scheme uses the similarity between the elements
to determine the position of the features in the matrix. The similarity-based visualization of the features
is obtained by using the dimensionality reduction technique called t-Distributed Stochastic Neighbor
Embeddings (t-SNE). This dimensionality reduction technique plots the high dimensional data onto a
lower dimensional space by using the patterns observed from the grouping of the data points based on
the similarity between the neighborhood points. The features in the dataset are represented as
datapoints in the analysis. The algorithm uses the difference between the probability of similarity
calculated over the higher dimensional space and the lower dimensional space for performing the
dimensionality reduction. The algorithm calculates the probability distribution for similarity of the points
under a Gaussian space placed over an area of the graph. This probability distribution has the
probabilities to show that one point in the Gaussian will select other points in the same space to be their
neighbors based on the similarity of the points. To get the best representation of the points on the lower
dimensional space, the algorithm tries to reduce the difference between the probabilities determined
over the high dimensional space and the low dimensional space. The algorithm calculates this probability
distribution for both high dimensional space and low dimensional space and use the Kullback-Leibler
divergence (KL Divergence). The algorithm uses gradient descent method to minimize the sum of KL
Divergence of the data points.
The kernel Principal Component Analysis technique can also be used to perform the dimensionality
reduction to obtain the genes' representation in the data set on a 2D plane. When the representation
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obtained using kPCA technique is used to transform the samples into images which are, further, used
for training the classifier, the classification model performs similar to the one trained using images
derived using the DeepInsight method involving t-SNE transformation.

Figure 9: Conversion of non-image data into images using DeepInsight method

The location of the genes on this cartesian plane is based on the similarity between the genes derived
using the t-SNE technique based on the entire dataset. Once, the location of features is determined on
the matrix, the gene expression values corresponding to each sample are mapped to the matrix.
After fixing the location of the features on the 2D matrix, the Convex Hull algorithm is applied to the
resultant matrix. The convex hull algorithm is used to enclose a given set of points using a polygon
constructed using the smallest set of points from the original set. In the DeepInsight method, the convex
hull algorithm is used to find the smallest possible rectangle that can enclose all the data points on the
2D plane representing the features in the dataset. Forming the smallest rectangle around the data points
helps to determine the frame containing all the points representing the location of genes on the 2D
representation. It also helps to discard the unwanted white space outside this rectangular enclosure and
get the smallest feature map containing the locations of all the genes in the input dataset. This helps in
reducing the image size by discarding the areas that are not useful for training the classifier. Also, the
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reduction in image size decreases the computation complexity for training the classification model using
images. When the high dimensional data is projected over the two-dimensional plane, it is possible that
the same pixel location can be allocated to multiple genes, leading to the overlapping of the genes on
that pixel. Implementation of a convex hull algorithm to determine the rectangular enclosure also helps
in reducing the count of overlapped features in the image. This is because when the unwanted white
space is removed, the actual frame to be considered as the feature map reduces in size. When this
reduced frame is mapped to a larger frame for feature mapping, the feature map gets zoomed in, and
the pixels are spread over to more precise locations on the feature map. This is because when the
unwanted white space is removed, the feature map will have a finer degree of granularity in terms of
discriminating the pixel locations. Consequently, two genes that fall into the same pixel location before
the convex hull was taken could be found residing in distinct pixel locations afterwards.

Figure 10: Example of images obtained after conversion of the gene expression data using DeepInsight

The framing of the image can be performed in a vertical or horizontal form, so this rectangular encloser
helps in determining the frame in which all the points fit in. Then a rotation is performed on the rectangle
obtained using the convex hull algorithm to align it with the horizontal and vertical axis. The location of
the features on the cartesian plane is converted into the pixel as a reference for all the samples. Using
these pixels’ locations specific to features (genes), the gene expression levels in the samples are mapped
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to the pixels on the plane. This process is repeated for all the samples in the dataset to produce image
samples corresponding to each sample's gene expression values. Figure 10 shows some of the images
obtained when the gene expression values are converted using this method. These images have been
selected from samples belonging to different cancer subtypes and represent the difference between the
image representations of the samples belonging to different classes.

4.1.2 2D Convolutional Neural Network

Convolutional Neural Networks are one of the most popular types of neural networks. Convolutional
Neural Networks are widely used for classification of visual imagery and can have a wide range of input
data like text, images, videos, computer vision and natural language processing. The most prominent
aspect of the convolutional neural networks is processing the input to extract the important features
and reduce the dimensions of the input so that the neural network consumes less amount of memory
and computational power to process the input and train the model. Convolution is a mathematical
function that computes a third function that represents how the value for one function is dependent of
another. The convolutions represent the relationship between the variables and define how the value
of one relation is revised when another is changed.
The convolutional neural network functions using the spatial and temporal dependencies between the
features. The spatial dependency between the features is captured based on the relationship that one
feature has with its neighboring features while the temporal dependency is captured by the means of
its location in the data in the sequence. The convolutional neural networks use filters to summarize the
data and extract the most important features from the input so that the neural network can be trained
to classify the input into different classes.
The convolutional neural networks consist of the convolutional layers which contains filters. For the
inputs provided to the convolutional layers, these filters slide over the input and perform matrix
multiplication to convert the input matrix into an activation map. The values in the activation map
depicts the location of the features detected in the input and their intensity defines the strength of the
features in the map. There can be multiple filters that can applied in one convolutional layer and their
outputs are combined together to form an activation map. The activation map has a reduced dimension
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compared to the input matrix and this makes it easier for the hidden layers to process it as an input. The
convolutional layers also provide a summarized version of features present in the input matrix which
results in highly specific features that can be detected anywhere on the input images.
We place the pooling layers next to a convolutional layer to further down sample the data matrix by
further summarizing the features in the data based on the patches covered by the filter that slides over
the input to this layer. This layer is used to generalize the nature of the features present in the input and
ensures that the model can learn the features irrespective of the location on the image or change in the
location of the image due to rotation, shifting, cropping among other changes in the image.
For our approach we have used a parallel architecture containing a combination of multiple sets of
convolutional and pooling layers. Each arm on the parallel architecture contains four sets of
convolutional layer and pooling layer configured using distinct number of filters and filter sizes to diverge
the values on the matrix to point precise position of features in the input. The second arm of the parallel
architecture has an identical configuration for the convolutional and pooling layer filters.
After the successive convolutional and pooling operations on the input, the output is flattened. The
flattening operation on the activation map converts the matrix into a single feature vector which is one
dimensional array. The flattening on the data is performed to convert the two-dimensional matrix into
a one-dimensional array so that it can be easily interpreted by the fully connected network. The output
of both the arms on the parallel architecture after flattening are merged together. To merge the output,
the architecture concatenates the outputs returned by both the arms into single one-dimensional array.
The operation of concatenation takes the input from both layers and link them together.

4.1.3 Adding raw data to the fully connected layer

After the output of the parallel convolutional architecture is passed to the fully connected layers, we
add the raw textual data to the fully connected layers by concatenating it to the output of the
convolutional layers. The primary idea behind adding the raw data in textual format to the fully
connected layers is to compensate for any type of information loss that is inflicted on the machine
learning model during any of the previous steps in the network.
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Figure 11: Feature density matrix representing the number of genes per pixel

In this approach, the gene expression data is converted into images using the DeepInsight methodology.
During this conversion, there is a loss of information due to the transformation of the data from text to
the images. While converting the coordinates derived from the dimensionality reduction method used
to pixel locations, some of the features in the sample are combined together by averaging their values
in order to fit them on the image due to pixel limitations. When the features are mapped onto the
cartesian plane, there are some features that are assigned the same pixel location on the frame. Hence,
their values are averaged and then placed on the same location. The number of features that overlap
depend on the size of the image that is derived. If the image size is small, the number of features that
have the same pixel location are higher as compared to the image frame with wider dimensions. Figure
11 presents a feature density matrix showing the number of genes mapped to a pixel on the 2D plane
after the transformation is performed on the data. This density matrix is obtained from the feature map
in 2D plane during the transformation of the gene expression data using DeepInsight involving t-SNE,
convex hull and other steps. The average number of overlapped gene representations in the feature
map are 8.2124 genes per pixel.
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Hence, due to this overlapping of the features in the image frame, the image representation does not
truly represent all the features in the dataset. The features that overlap each other lead to a loss of the
importance given to individual features and result in loss of information that could have been derived
from those features if they were considered separately.
This loss of information provides a window of improvement for this image-based classification method.
Our proposed method utilizes the data that is initially used for this classification task and contains all the
features with their values defined separately. Hence, the proposed method uses the data in its raw
format to compensate for the loss of information that the model occurs due to the transformation of
the data.

4.1.4 Classification using softmax activation function

After the processed inputs are passed to the fully connected layers, the neurons' weights are determined
in the forward propagation during the training of the model. The softmax activation function is used to
convert the output to the probability distribution over the output variables/classes. The softmax
function takes in the vector input from the fully connected layer. It normalizes it to represent the
distribution of probability over the target predicted outcome with all the components in the output
adding up to 1. The formula for softmax function is depicted in equation 4.4:

𝜎(𝑧)𝑖 =

𝑒 𝑧𝑖
∑𝑘𝑗=1 𝑒 𝑧𝑗

where:
𝜎 = represents the softmax function
z = input vector
𝑒 𝑧𝑖 = exponential function for each element zi in the input vector
K = number of classes in the multi class classifier

(4.4)
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4.2 Evaluation Metrics

The initial dataset is split into two, namely the training and testing dataset, to evaluate a machine
learning model. The model is trained using the training dataset, and to measure the performance of our
trained model, the testing dataset is fed to the trained model to predict the target variable for the
samples. To evaluate the correctness of the trained model, we are using Classification Accuracy and
Precision as our evaluation metrics.

4.2.1 Classification Accuracy

Classification Accuracy is defined as the average number of correct predictions provided by the trained
model. Mathematically, it can be defined as the ratio of correct predictions to the total number of
predictions.
𝐶𝑙𝑎𝑠𝑠𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =

𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑟𝑟𝑒𝑐𝑡 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛𝑠
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑜𝑛𝑠

(4.5)

4.2.2 Precision
Precision is used to measure the quality of predictions taking into account the correct predictions only.
It is the ratio of correct positive results to the total number of positives predicted by the model. The
precision score provides a broader outlook on a classification model's performance as it considers the
misclassification rate of the minor class samples.
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =

𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + 𝐹𝑎𝑙𝑠𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠

(4.6)

4.2.3 Performance Metrics
In order to evaluate the quality of the proposed approach, we compare our method with the state-ofthe-art methods in this context. In addition to the state-of-the-art methods, we performed experiments
by implementing these methods for the dataset with which we are evaluating the performance of the
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proposed approach and adding the raw data to the fully connected layers. This provides a fair
comparison and would help in establishing that feeding the raw data to the architecture improves the
quality of the overall architecture. We use the DeepInsight method and method proposed by Lyu et al
involving the use of gene expression data ordered using chromosome locations and converting the
samples to images as the baseline model for this thesis. We compare the proposed approach with the
following models:
•

1D Convolutional Neural Network
o

Input data ordered based on the covariance between the genes

o

Input data ordered based on the chromosome locations

•

DeepInsight Method

•

Method proposed by Lyu et al in “Deep Learning Based Tumor Type Classification Using Gene
Expression Data”

4.2.3.1 1D Convolutional Neural Network

The basic concept behind a convolutional neural network is to understand the patterns and relationships
between the features. Therefore, the 2D CNN is generally recommended for image classification. Since
we have textual data in which the input structure can be altered to provide a meaningful relationship
between the features and make use of the feature extraction capabilities of the convolutional
architecture on a 1D dataset. The idea behind the architecture used in a 1D CNN is similar to the 2D
CNN. The only difference is using a single dimension of data in all layers instead of two dimensions while
processing image data.
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Figure 12: Architecture for 1D Convolutional Neural Network

In the raw dataset, the data is structured using an arbitrary ordering scheme. Hence to use the features
of the convolutional layers, we re-order the data to provide a meaningful relationship between the
features to get a better performance out of the 1D CNN architecture. The architecture used for
implementation is shown in figure 12. In order to instill a relationship between the features in the data,
we implement the 1D CNN by ordering the features based on two schemes:
•

Covariance scores of the features – The genes are ordered based on the covariance score, which
places the genes based on the joint variability of the gene intensity levels observed throughout
the dataset. For determining the covariance score, we perform the principal component analysis
on the dataset. The features in the data are ranked based on the scores obtained from the
principal component analysis. For ranking the features, the explained variance ratio is used, and
the features are ranked in the descending order based on the explained variance score
associated with the features. The explained variance score corresponding to the features define
the amount of variance that is represented by each component. The estimation of the variance
uses the (number of samples – 1) degrees of freedom. The degrees of freedom are the number
of independent values that do not depend on the value of other features logically and have the
freedom to vary and are used to calculate the estimate.
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•

Chromosome locations – The genes are ordered based on the location of the genes on the
chromosomes. We use the Human Genomics Nomenclature Committee (HGNC) dataset to get
the information about the location of the gene on the chromosome. In order to use these
locations, we perform the feature selection on the raw data based on the genes that are
common in the TCGA dataset and the HGNC dataset. The location of the gene on the
chromosome is represented using the locus format (3p22.1). The locations expressed using the
locus format consists of four components:
o

Chromosome Number: The first component of the location represents the chromosome
number on which the gene is located. There are 23 pairs of chromosomes in humans.

o

Arm of Chromosome: The chromosomes in humans form a four-arm structure attached
to each other at the centromere that acts as a link between these arms. The shorter arm
is known as ‘p’ arm and the longer arm is named as ‘q’ arm.

o

Region and Band: The third component represents the location of the gene on the
chromosome arm. The chromosome arms are divided into regions. There are 3 regions
on the shorter arm and 5 on the longer arms. The regions are divided into bands that
are visible when the chromosome samples are stained.

o

Sub-band: The bands on the chromosome regions are further divided into sub-bands
which are visible at a higher resolution when the chromosome sample is stained.

Based on the chromosome location, we first sort the genes based on the chromosome
number to arrange them in an ascending order. For genes belonging to a chromosome
number, we sort them based on the arm of the chromosome on which they are situated.
Then we perform the sorting of the genes based on the bands and the sub-bands on which
the genes are located on the chromosome.
In addition to the above setups, we studied the impact of adding the raw data to the 1D CNN trained
using the above schemes.
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4.2.3.2 DeepInsight Method

This approach is used as a base model for the study of this proposed approach, and we compare both
the approaches to calculate the scope of improvement offered by adding the raw data to the model.
The essence of the DeepInsight approach is the method of conversion of non-image data to images that
the convolutional neural networks can process. For this comparison, we convert data into images and
train the convolutional neural network and evaluate the model using the evaluation metrics defined
above.

4.2.3.3 Method proposed by Lyu et al in “Deep Learning Based Tumor Type
Classification Using Gene Expression Data”

The method proposed by Lyu et al. in their research proposes to convert the gene expression data to
images. The transformation scheme involves feature selection using the NCBI data set and preprocessing
the data by performing normalization. After treating the data below a threshold and ordering the
features based on the chromosome number on which the gene is situated it transforms the data into a
matrix which is then embedded into images. They used the images obtained to train a convolutional
neural network for performing the cancer subtype classification.
Figure 13 shows the conversion of the 1D gene expression data to a 2D matrix. The table represents the
list of the genes and the location of the gene on the chromosome. The values are sorted as per the
location of the gene on the chromosome. To transform this data into a 2D matrix, the input data is
reshaped into a 2D matrix by adding the values to the matrix from the input row by row. It is more likely
that there is more interaction between the adjacent genes, and this represents the motive of adding a
meaningful relation between the features by ordering them based on chromosome numbers. However,
when the data is converted into the 2D matrix, some of the relations are lost between the data. In figure
12, we can see that the G06 gene had to be placed in the second row, which leads to a loss of relation
between G05 and G06. It also leads to a new relation between G06-G01-G07-G11-G12-G02 as these
genes are present in the vicinity of G06. However, in reality, it is possible that these genes are not tightly
related to each other.
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Figure 13: Transformation of chromosome ordered data into matrix

We use the images obtained by the transformation scheme proposed by Lyu et al. and add the raw data
to the fully connected layers in the architecture proposed in the referenced study as shown in figure 14.
The results will be used to establish the soundness of the claim that the model performance can be
improved by passing the raw data to the fully connected layers. Figure 15 shows the example of images
that are obtained after the conversion of gene expression using Lyu et. al’s proposed approach. These
images have been selected from samples belonging to different cancer subtypes and represent the
difference between the image representations of the samples belonging to different classes.
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Figure 14: Architecture illustrating the use of raw gene expression data and the images derived from the gene expression data
ordered using the chromosome locations (method proposed by Lyu et. Al)

Figure 15: Example of images obtained using method proposed by Lyu et. al
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Chapter 5
Experiments, Discussions, Comparison and
Analysis
This chapter includes details about the experimental setup, including the technologies, tools, and
platforms used to implement the proposed approach. This chapter will also include the system
configurations, model training and testing, CNN configurations with specifications of the layers
implemented, and evaluation methods used to quantify the performance of the proposed approach. We
will also present the results of the tests conducted using the dataset. To evaluate the effectiveness of
the proposed approach, we have compared it with state-of-the-art methods like DeepInsight, the
method proposed by Lyu et al., and its sibling in a one-dimensional convolutional neural network. In
order to do so, we have implemented the above methods and evaluated their performance using the
cancer dataset. To further test the impact of adding the raw data to the model, we have supplemented
the above-stated state-of-the-art methods with the raw training data to compare them and our
proposed method. To get optimal performance out of the one-dimensional convolutional neural
network, we have implemented two versions of the 1D CNN by training the same using two different
schemes of the feature ordering in the training data. Since the features in the data set represent the
gene intensity levels of the genes in tumor tissue, we have reordered the features in the dataset using
covariance between the genes and the location of the genes on the chromosomes. We study the nature
of our dataset by using the Principal Component Analysis and represent the distribution of the cancer
types on a 2D plane with the help of a scatterplot.
We illustrate the performance of the proposed model and compare the same with the state-of-the-art
methods by using the bar graphs that will be showing the comparison based on the Classification
Accuracy and Precision that is observed using each approach.
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5.1 Tools and Libraries

We implemented our proposed approach using Keras with Python 3.7.10 programming language. The
libraries and their versions that are used to implement our proposed approach are as listed below:
•

TensorFlow 2.4.0

•

Pandas 1.1.5

•

Numpy 1.19.5

•

Seaborn 0.11.1

•

Keras 2.4.0

•

Sklearn 0.22.2.post1

•

OpenCV 4.1.2

•

Matplotlib 3.2.2

We used Jupyter notebook to implement and test the methods discussed in this work.

5.2 System Configurations

Data preprocessing, training of the model, and testing were done using the Jupyter notebook hosted on
Google Colaboratory (also known as Google Colab). Google Colab is used to code and execute python
scripts using browsers and can be used to implement machine learning and data analytics techniques.
We used the Tensor Processing Unit (TPU) to empower the machine learning projects implemented
using TensorFlow using custom-built processors by Google. Google Colab provides a TPU with 12.69 GB
of RAM and 107 GB of memory.

5.3 Dataset

The main idea behind our proposed method is to classify cancer subtypes using the RNA sequence data.
We have used the cancer dataset generated by The Cancer Genome Atlas (TCGA) program. TCGA
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program is a joint effort led by National Cancer Institute and National Human Genome Research
Institute. The study was aimed at understanding molecular dynamics through the application of genome
analysis techniques. Specific alterations in the gene intensity level of various genomic expressions can
be linked to different subtypes of cancers and studying these variations can aid in classifying and
identifying various subtypes of cancers.
For collecting the data for this analysis, the requirement of the tumorous tissue extraction depended on
the type of cancer to be analyzed and the site of the tissue extraction. The process of tissue extraction
includes retrieval of the tumorous sample by biopsy for studying. The tissues are immobilized to isolate
the biomolecules from the sample. Genomic Characterization Centers analyze the samples to identify
the changes in genes for various tumor types by generating the mRNA and miRNA expression data. The
samples are then passed to Genomic Sequencing Centers to perform next-generation sequencing that
is used to determine those small genetic variations pertaining to disorders or pathological conditions.
The gene-specific probes are used by the gene sequencers to measure the gene intensity levels from the
sample. [45]

Figure 16: Distribution of number of samples among different cancer subtypes
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There are various cancer genomics data and analysis resources that use the gene sequences obtained
by the Genomic Sequencing Centers to perform the analysis on the data and present this data in forms
of somatic mutations, DNA copy-number alterations (CNAs), mRNA and microRNA (miRNA) expression,
DNA methylation, protein abundance, and phosphoprotein abundance. The cancer genomics data and
analysis resources that perform this analysis include the ICGC data portal, the Broad Institute's Genome
Data Analysis Center (GDAC) Firehose, the IGV, the University of California, Santa Cruz (UCSC) Cancer
Genomics Browser, IntOGen, Regulome Explorer, Oncomine (Reserach Edition), etc. These analysis
resources transform the above stated data forms by performing statistical operations to normalize the
data so that it can be used easily to train machine learning models.
The dataset used for this study contains median values for the gene expression levels of all expressed
genes in the RNA sequence. The dataset contains median values for 20,531 expressed genes which are
used as features for training the classification model. The dataset contains data for 6943 samples
distributed over 20 cancer subtypes. One sample in the dataset represent the gene intensity levels of
20,531 expressed genes in one tumorous tissue analyzed using the gene sequencing data with the
Firehose Legacy framework developed by The Broad Institute of MIT and Harvard. The distribution of
the cancer subtypes in the dataset is shown in figure 16.

5.4 CNN Configurations

Our proposed approach implementation involves using convolutional neural networks as the classifiers
to identify cancer subtypes. We used a parallel architecture that consists of multiple sets of the
combinations of convolutional layers from CNNs and the pooling layer. In each arm of the parallel
architecture, there are four sets of one convolutional layer and one pooling layer placed sequentially.
The arms' output is combined by concatenating them, which is then passed to the fully connected
layers. The details of the CNN and tunable parameters are shown in table 5.1.
Layer

Specifications

Activation Function

Arm 1
Convolutional Layer

6 filters with kernel size 2x2

None

Max Pooling Layer

Pool size of 2x2

None
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Convolutional Layer

4 filters with kernel size 3x3

None

Max Pooling Layer

Pool size of 2x2

None

Convolutional Layer

2 filters with kernel size 4x4

None

Max Pooling Layer

Pool size of 2x2

None

Convolutional Layer

2 filters with kernel size 4x4

None

Max Pooling Layer

Pool size of 2x2

None

Flatten Layer

Flattens pooled matrix

None

Dense Layer

20 neurons

ReLu
Arm 2

Convolutional Layer

6 filters with kernel size 2x2

None

Max Pooling Layer

Pool size of 2x2

None

Convolutional Layer

4 filters with kernel size 3x3

None

Max Pooling Layer

Pool size of 2x2

None

Convolutional Layer

2 filters with kernel size 4x4

None

Max Pooling Layer

Pool size of 2x2

None

Convolutional Layer

2 filters with kernel size 4x4

None

Max Pooling Layer

Pool size of 2x2

None

Dense Layer

20 neurons

ReLu

Combination of outputs
Concatenate Layer

Concatenates the outputs

Processing raw data to be added to fully connected layers
Dense Layer

1020 neurons

ReLu

Dense Layer

512 neurons

None

Dense Layer

128 neurons

None

Dense Layer

20 neurons

ReLu

Adding raw data to fully connected layers
Concatenate Layer

Concatenates the outputs
Generating output

Output Layer

20 neurons
Table 5.1: Configurations of the model for proposed approach

Softmax
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5.5 Training and Testing

We performed the training of the model over 50 epochs with a batch size of 256. For the model training,
we used a validation split of 0.2, which split the training data in such a way that during each iteration.
80% of data is used for training, and 20% is used as a validation set. We partitioned our initial data set
into a training set containing 80% of the data and the testing set containing 20% of the data. The testing
set is used to evaluate the performance of the trained model. Since this is a multi-class classification
problem, we used the categorical cross-entropy as the loss function for compiling the model. After the
model is trained on the training set, we test it using the testing set and determine the Classification
Accuracy and Precision using the predictions.

5.6 Comparison and Analysis
5.6.1 The Cancer Genome Atlas (TCGA) Dataset

We have used the TCGA dataset for training and testing our proposed approach. We have implemented
the same using the TCGA dataset and calculated the classification accuracy and precision for these
approaches for comparison with the state-of-the-art approaches. We have used the data processed
using the Firehose analysis infrastructure developed by the Broad Institute of Massachusetts Institute
of Technology and Harvard University for evaluating the models. We used the files with the median
values of expression levels of all the expressed genes in an RNA sequence from the data present in this
dataset. For every sample, the data contains the gene expression values for 20,531 expressed genes.
Table 5.2 shows the number of samples per the cancer subtypes present in the dataset we used for
analysis.
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Figure 17 displays the principal component analysis of the dataset using two principal components. The
analysis portrays a distinction between various cancer subtypes while some classes have overlapping
regions with other classes.

Disease Name

Cohort

Number of samples

Adrenocortical carcinoma

ACC

79

Bladder urothelial carcinoma

BLCA

408

Breast invasive carcinoma

BRCA

1100

Cervical and endocervical cancers

CESC

306

Cholangiocarcinoma

CHOL

36

COADREAD

382

Lymphoid Neoplasm Diffuse Large B-cell Lymphoma

DLBC

48

Esophageal carcinoma

ESCA

185

Glioblastoma multiforme

GBM

166

Head and Neck squamous cell carcinoma

HNSC

522

Acute Myeloid Leukemia

LAML

173

Brain Lower Grade Glioma

LGG

530

Liver hepatocellular carcinoma

LIHC

373

Lung squamous cell carcinoma

LUSC

501

OV

307

Pancreatic adenocarcinoma

PAAD

179

Prostate adenocarcinoma

PRAD

498

Sarcoma

SARC

263

Skin Cutaneous Melanoma

SKCM

472

Stomach adenocarcinoma

STAD

415

Colorectal adenocarcinoma

Ovarian serous cystadenocarcinoma

Total
Table 5.2: The Cancer Genome Atlas dataset sample counts per cancer subtype

6943
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Figure 17: Principal Component Analysis for the TCGA dataset

As per the principal component analysis of the dataset for cancer subtypes, table 5.3 shows the
expressed variance ratio in 15 principal components, which account for almost 96% of the variance. The
first two principal components, which account for 71% of the variance combined, are used most
commonly.

Component

Explained Variance Ratio

Cumulative Explained Variance Ratio

Principal Component 1

0.44828848

0.44828848

Principal Component 2

0.26503148

0.71331996

Principal Component 3

0.06969009

0.78301005

Principal Component 4

0.04477991

0.82778996

54
Principal Component 5

0.03844587

0.86623584

Principal Component 6

0.03300874

0.89924458

Principal Component 7

0.01586363

0.91510822

Principal Component 8

0.00792615

0.92303436

Principal Component 9

0.00776632

0.93080069

Principal Component 10

0.00749964

0.93830032

Principal Component 11

0.00522778

0.94352811

Principal Component 12

0.00462637

0.94815448

Principal Component 13

0.00443642

0.9525909

Principal Component 14

0.00394105

0.95653195

Principal Component 15

0.00345941

0.95999136

Table 5.3: Principal components as calculated by PCA algorithm

Figure 18: Plot showing distribution of Explained Variance Ratio and Cumulative Explained Variance Ratio

5.6.2 The Human Genomic Nomenclature Committee Dataset

For performing the feature selection, we have used the Human Genomic Nomenclature Committee
(HGNC) dataset. HGNC is a committee that is responsible for approving the unique symbols and names
of the human loci, which includes protein-coding genes, ncRNA genes, and pseudogenes. They maintain
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a record of this information regarding the genes to facilitate unambiguous scientific communication
related to human genomics. We selected only those genes from the Firehose Legacy dataset that are
present in the HGNC dataset. For the one-dimensional CNN model, we use the chromosome location
present in the HGNC dataset to reorder the data based on the location of the gene on the chromosome.

5.6.3 Performance Comparison

For comparing the performance of our proposed approach to state-of-the-art methods, we
implemented these methods. We evaluated the performance using the cancer subtypes from the TCGA
dataset defined above. We considered the following approaches for comparing the performance of the
proposed method:
•

•

One Dimensional Convolutional Neural Network
o

with genes ordered using covariance between features

o

with genes ordered using chromosome location

Two Dimensional Convolutional Neural Networks trained using DeepInsight (methodology to
convert non-image data to images)

•

The method proposed by Lyu et al. in “Deep Learning-Based Tumor Type Classification Using
Gene Expression Data”

5.6.3.1 Performance Evaluation on 1D Convolutional Neural Networks

For implementing the 1D CNN, we have used the HGNC dataset for performing the feature selection on
the dataset. We observed a significant increase in the accuracy of the predictions when the feature
selection is implemented. We observed an accuracy of 0.691 when 1D CNN is implemented using the
raw dataset, and on feature selection, the accuracy increases to 0.894.
The process of feature selection is widely used to preprocess the dataset that is used to train a machine
learning model. Feature selection is referred to the process of downscaling the test data used for training
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the model in order to remove the irrelevant data from the dataset. An increase in the accuracy is
observed because removing non-important features can decrease the noise in the data and help in
improving the distinction between different classes in the dataset.
To compare our proposed model with an optimal solution using 1D CNN, we performed feature reordering using two transformation schemes- covariance and chromosome locations. The main idea
behind ordering the features based on the covariance between the features and the chromosome
location is to leverage the relationships between the features. The convolutional neural networks can
summarize the input better when the features in the sample are correlated with each other and can
perform efficient feature extraction. When the data with features in a meaningful sequence are fed to
the convolutional neural networks, they process the inputs to extract the essential features that can aid
in identification and differentiation between the samples of different classes.
Figure 19 shows the comparison of classification accuracies between the 1D CNN setups explained
above. A significant increase can be observed when feature selection is implemented on this data set.
The classification accuracy is further improved when the features are ordered based on covariance and
the chromosome locations.
The addition of the raw data to the model further increases the classification accuracy and precision.
From figure 20, we can see a considerable increase in accuracy in the model, which is trained using the
features ordered using the chromosome locations. A similar upward pattern can be observed for the
precision measurement for the same dataset on using the raw data in addition to the processed dataset.
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Figure 19: Classification Accuracy comparison for 1D CNN

Figure 20: Comparison of classification accuracy between the covariance and chromosome ordered 1D CNN setup and the 1D
CNN with raw data
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For the data with features ordered using the covariance between the genes, an increase of 1% is
observed in the accuracy when we provide supplementary data during the model training. In addition
to this, figure 21 shows that the precision also improves for the model and increases from 93% to 94%.
Based on the results, we observe that the model with features ordered based on covariance performs
better than the model with features ordered using the chromosome locations in terms of classification
accuracy. However, the case is the opposite when the raw data is added to the fully connected layers,
which tantamount to a better performance shown with chromosome location-based ordering than the
covariance-based ordering.

Figure 21: Comparison of precision between the covariance and chromosome ordered 1D CNN setup and the 1D CNN with raw
data

5.6.3.2 Performance Evaluation of 2D Convolutional Neural Network using the
proposed approach with DeepInsight

The DeepInsight method provides a significant improvement over the existing approaches by converting
non-image data into images. The authors reported promising results when compared to the techniques
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like Random Forest, Decision Tree, and Ada Boost. We implemented the same conversion technique
using the TCGA dataset with a median of the gene expression values of the expressed genes for our
experiments.
After converting the dataset with gene intensity values to images using the DeepInsight method, we
passed those images to the 2D CNN parallel architecture with two arms, each containing multiple sets
of convolutional layers and pooling layers connected in series, as discussed in the proposed method
section and fine-tuning the hyperparameters to obtain highest possible performance, we observed a
classification accuracy of 0.9251 and the precision score of 0.9300.

Figure 22: Impact of adding raw data on 2D CNN architecture using DeepInsight Method of image conversion

In order to add the raw data to the setup, we read the datasets in addition to the images pertaining to
the cancer samples and first trained the parallel architecture performing the convolutional task and
combined the outputs of the two arms of the parallel architecture employing concatenation. We pass
the result of the concatenation to the fully connected layers and feed the raw data to the fully connected
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layer by concatenating it to the output of the convolutional setup. With this setup, we observe a
classification accuracy of 0.9720 and a precision score of 0.9726.
From figure 22, we can see a significant increase in the classification accuracy score from 0.9251 to 0.972
on adding the raw data. The most viable explanation for this is that the addition of raw data compensates
for the loss of information that occurs when the data is converted into images. The placement of the
genes on the 2D plane by means of tSNE or KPCA leads to an overlap of some gene locations on the
graph, which leads to the loss of the gene intensity levels for those specific genes. The provisioning of
the raw data to the fully connected layers compensates for the loss and adds to the classification
accuracy of the method.

Figure 23: Impact on Precision score after adding raw data on 2D CNN architecture using DeepInsight Method of image
conversion

A similar increase in the precision score evaluated using these approaches is shown in Figure 23,
demonstrating that the precision increases from 0.9300 to 0.9726 after the raw data is passed to the
fully connected layers in the approach. Hence, the addition of the raw data in the fully connected layers
leads to an increase in the performance of the 2D CNN approach implemented using the DeepInsight
method.
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5.6.3.3 Performance Evaluation of 2D Convolutional Neural Network using the
approach proposed by Lyu et. Al

The method proposed by Lyu et al. provides a comprehensive approach on how to use the annotation
file from NCBI to select genes and normalize the data. Their approach also performs substitutions in the
data based on a certain threshold by replacing the values below the threshold value in the dataset. We
implemented the method proposed by Lyu et al. using the TCGA dataset that we are using to calculate
the classification accuracy and precision score.
For this implementation, we used the NCBI annotation file used by the authors for selecting the genes
for our experiments and used the logarithmic normalization to normalize the data before conversion to
images. After training the model using the images obtained after conversion, we observed a
classification accuracy of 0.9318 and a precision score of 0.9371.
For a comparison with our proposed approach, we added the raw data component to the model. After
the 2D convolutional layer and pooling layer lead to a convolved matrix, we pass the same to the fully
connected layers. In addition to this output, we added the raw data by concatenating the same to the
output of the convolutional layers. After concatenation, the fully connected layers process the data and
use the softmax function to convert the result into a probability distribution of the desired classes. The
experiments performed on the above result after fine-tuning the network, results in a classification
accuracy of 0.9590 and a precision score of 0.9595.
Figure 24 shows that Lyu et al.’s method also presents the upward trend for classification accuracy seen
in the rest of the experiments. The classification accuracy increased by a factor of 2.72% when the raw
data is added to the fully connected layers. Similarly, figure 25 shows an increase of 2.24% in the
precision scores when the raw data is fed to the fully connected layers.
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Figure 24: Comparison of Classification Accuracy before and after adding raw data to [Lyu]’s method

Figure 25: Comparison of Precision Score before and after adding raw data to [Lyu]’s method
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5.6.3.4 Comparison of performance among all the methods

From the results explained in the previous sections, we can see that the proposed approach of adding
raw data to the fully connected layers of a convolutional model improves the model's performance and
provides better classification results on the testing set. On comparing all the methods, the 2D CNN
model trained using images derived by the DeepInsight method with raw data added to the fully
connected layers emerges as the best performing model from the models on which the experiments
were conducted. The 2D CNN trained with this technique shows the best classification accuracy and the
precision score.
Comparing the classification accuracy score among the models shown in Figure 26, we can see that the
models in which the raw data was added to the fully connected layers perform better than the models
in which it is not added. The results also show that the methods which use 2D CNN for classification
perform better than the 1D CNN classifiers when the raw data is added to the fully connected layers.

Figure 26: Comparison of classification accuracy among different models

64
The addition of the raw data to the fully connected layers compensates for the loss of information more
in methods that use 2D data for training the classifiers than the models with 1D classifiers. Although
smaller than 2D classifiers, the 1D classifiers also show an improvement in the performance when raw
data is added. Hence, from the classification accuracy standpoint, it can be seen in Figure 26 that the
addition of the raw data component in the model lead to an increase in its value leading to better
classification results.
Figure 27 portrays a similar upward trend in the precision score of the models used for experiments. All
the models experience an increase in the precision score upon the addition of raw data to the fully
connected component of the network. Similar to the classification accuracy, we can see that the models
where the raw data was passed to the fully connected layers have a higher precision score than the
others. In terms of precision score, a 2D CNN classifier trained using the images derived using the
DeepInsight method and with raw data has the highest precision score compared to other setups. This
method's highest increase in precision is also experienced when raw data is added to the fully connected
layers as the precision score increased from 0.93 to 0.9726. When the images are converted using the
DeepInsight method, the dimensionality reduction techniques lead to a certain amount of loss of
information in the data. This is because when features are visualized in a 2D, the placement of features
is done in a condensed space, and many features overlap each other in the plan. Hence, with the features
overlapped, we lose some information that can be compensated by adding the raw data to the fully
connected layers. From figure 26 and figure 27, we can say that our proposed method consistently
performs better than other methods supporting the addition of raw data to the fully connected layers
in a classification model.
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Figure 27: Comparison of precision score among different models
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Chapter 6
Conclusion and Future Work
6.1 Conclusion

With cancer being one of the leading causes of death globally, there is a need to determine new
techniques that would enable doctors and pathologists to detect the problem earlier in the stage, which
helps increase the survival rate in the patients. Genomic testing is one of the most viable approaches
that can be implemented at a broad scale for early detection. Precision medicine is another domain in
this area that is influenced by the results of genomic testing. Our proposed approach aims at improving
the machine learning algorithms using Convolutional Neural Networks to train models for performing
the classification and prediction tasks. We propose a method that uses the Convolutional Neural
Network trained using the images derived from the RNA gene expression data to perform cancer
subtype classification. This architecture aims to improve the classification quality and compensate for
the loss of information incurred due to various transformations performed on the data. The existing
state-of-the-art methods use two-dimensional convolutional neural networks trained using images
converted from the textual gene expression data. However, due to this conversion from text to images,
these methods suffer from losing information in one form or another. These conversions may lead to
information loss due to overlapping features when the features are visualized to be converted to images
or lose the spatial relationship between the elements when converted to images after converting the
one-dimensional array to a two-dimensional matrix. We also study the implementation of 1D CNN using
data structured using two schemes i.e., covariance between the features and location of the gene on
the chromosome and evaluate the proposed approach by implementing it on top of these methods.
Our proposed approach involves providing the raw data to the fully connected layers to compensate for
any type of information loss that the neural network occurs. The architecture of the existing methods
can function as they are designed when the convolutional layers have performed their operation on the

67
input; the raw data set can be provided to the fully connected layers to supplement the output from the
convolutional layers.

6.1.1 Discussion

This thesis research studied the impact of providing the raw gene expression data to the fully connected
layers. We performed various experiments to determine the classification accuracy and the precision
score for comparing different approaches. We mainly focused on comparing the DeepInsight approach
proposed by Sharma et al. and the approach proposed for Lyu et al., which uses the two-dimensional
convolutional neural networks and involve the conversion of the gene expression data to images for
training the neural network model. We also implemented the one-dimensional convolutional neural
networks that are trained used the data transformed using two different methods- covariance-based
ordering and the gene location on the chromosome-based ordering. We changed the data structure to
inject a relationship between the features as the convolutional neural networks leverage these spatial
and temporal relationships in the data for learning about the features and the patterns that exist in data.
From our experiments, we analyzed that the addition of the raw gene expression data leads to improved
classification accuracy and precision scores for all the approaches. We observed that the approach
implemented using the raw gene expression data provisioned to the fully connected layers lead to better
classification results and less overfitting in the models.
Since convolutional neural networks are widely used in performing the classification of disease subtypes
using different types of data, this approach can improve the classification quality of the machine learning
methods in various domains.
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6.2 Future Work

From our experiments using convolutional neural networks trained with the gene expression data, we
can see that every time we provide the raw gene expression data to the fully connected component, the
network's performance improves. This technique can be extrapolated to work with a different type of
data to understand the applicability of this approach across other datasets. This approach can be used
for different types of textual datasets for performing the classification into subtypes by using
convolutional neural networks. These datasets can be of medical significance and represent gene
expression or other forms of data for genomic testing recorded for different diseases. Apart from the
medical domain, this approach can be implemented to determine the impact of provisioning the raw
data to the fully connected layers for other datasets related to sentiment analysis, stock prediction, and
classification tasks in natural language processing.
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